Obesity Organizations Release Consensus Statement
Six organizations that focus on the diagnosis and treatment of obesity have released a consensus statement to reduce barriers to care.
Six organizations that focus on the diagnosis and treatment of obesity have released a consensus statement to reduce barriers to care.
Researchers sought to determine whether fecal microbiota transplantation from a lean donor contributes to an improvement in bariatric surgery outcomes.
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
Sibutramine is a controlled substance that was voluntarily withdrawn from the market in October 2010.
Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
Researchers at Memorial Sloan Kettering Cancer Center conducted a study to determine which diet is better at reducing cancer risk and improving health: keto or plant-based.
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Imcivree is a melanocortin 4 receptor (MC4R) agonist that re-establishes MC4 receptor pathway activity to reduce hunger and promote weight loss.